Naive T cells undergo metabolic reprogramming to support the increased energetic and biosynthetic demands of effector T cell function. However, how nutrient availability influences T cell metabolism and function remains poorly understood. Here we report plasticity in effector T cell metabolism in response to changing nutrient availability. Activated T cells were found to possess a glucose-sensitive metabolic checkpoint controlled by the energy sensor AMP-activated protein kinase (AMPK) that regulated mRNA translation and glutamine-dependent mitochondrial metabolism to maintain T cell bioenergetics and viability. T cells lacking AMPKa1 displayed reduced mitochondrial bioenergetics and cellular ATP in response to glucose limitation in vitro or pathogenic challenge in vivo. Finally, we demonstrated that AMPKa1 is essential for T helper 1 (Th1) and Th17 cell development and primary T cell responses to viral and bacterial infections in vivo. Our data highlight AMPK-dependent regulation of metabolic homeostasis as a key regulator of T cell-mediated adaptive immunity.
Correspondence russell.jones@mcgill.ca In Brief T cells undergo metabolic reprogramming upon activation to fuel T cell growth, proliferation, and effector function. Jones and colleagues show effector T cells adapt their metabolic programs in response to reduced glucose availability, which is regulated by the energy sensor AMPK.
INTRODUCTION
T lymphocytes are central effectors of the adaptive immune response, and their function is critical for long-lasting immunity to foreign pathogens. While T cell activation initiates specific transcriptional programs that direct T cell differentiation and effector function, the regulation of cellular metabolism is also integrated into the T cell activation program (MacIver et al., 2013; Wang and Green, 2012b) . Upon activation, naive T cells shift toward a pro-growth metabolic program characterized by increased glucose and amino acid metabolism (Carr et al., 2010; Frauwirth et al., 2002; Nakaya et al., 2014; Sinclair et al., 2013; Wang et al., 2011) . The predominant metabolic phenotype of activated CD4 + and CD8 + T effector (Teff) cells in vitro is a shift to aerobic glycolysis (Michalek et al., 2011a) , also known as the ''Warburg Effect.'' Transcription factors including Myc (Wang et al., 2011) , estrogen-related receptor a (ERRa) (Michalek et al., 2011b) , and the liver X receptors (LXRs) (Bensinger et al., 2008) facilitate T cell metabolic reprogramming by enhancing the expression of metabolic genes downstream of TCR signaling, which allow Teff cells to meet the bioenergetic and biosynthetic requirements of cell division and effector function. Nutrient availability can have a profound effect on T cell activation and function. Limiting glucose or glutamine in culture medium decreases the activation of naive T cells and subsequent T cell proliferation (Ardawi and Newsholme, 1983; Brand, 1985; Carr et al., 2010; Jacobs et al., 2008; Wang et al., 2011) . Consequently, reduced nutrient availability during early activation impairs interferon-g (IFN-g) production by CD4 + and CD8 + Teff cells in vitro (Cham et al., 2008; Cham and Gajewski, 2005; Chang et al., 2013) . Recent work indicates that the development and function of Teff cells in vivo can be influenced by changes in nutrient transport (Macintyre et al., 2014; Nakaya et al., 2014; Sinclair et al., 2013) . However, the mechanisms by which T cells couple changes in nutrient availability to immunologic function remain poorly understood. This is an important issue, as effective adaptive immunity requires Teff cells to expand, survive, and maintain effector function in a range of microenvironments, including sites of infection or inflammation where nutrients and oxygen might be limiting (McNamee et al., 2013; Sitkovsky and Lukashev, 2005) . Here we examined the impact of nutrient availability on Teff cell metabolism and function. We provide evidence for plasticity in T cell metabolic reprogramming, a process regulated by the energy sensor AMP-activated protein kinase (AMPK).
RESULTS

Glucose Limitation Induces a Metabolic Checkpoint in T Cells
In many cell types, nutrient limitation induces a metabolic checkpoint that limits cell proliferation and growth when resources are scarce. Thus, we investigated the relationship between nutrient availability, effector function, and metabolism in activated Teff cells. CD4 + or CD8 + Teff cells were generated via anti-CD3
and anti-CD28 antibody stimulation with interleukin-2 (IL-2) for 3 days, followed by acute glucose starvation (ÀGlc) for 5 hr prior to characterization ( Figure 1A ). Overnight glucose starvation slowed the proliferation of both CD4 + and CD8 + Teff cells ( Figure S1A ). Activated CD8 + Teff cells re-stimulated under decreasing levels of glucose displayed a dose-dependent decrease in IFN-g production ( Figure 1B ). Reducing glucose concentrations below 25 mM (standard concentration in IMDM) decreased both the percentage of IFN-g + CD8 + T cells ( Figure 1B ) and the mean fluorescence intensity (MFI) of IFN-g staining for IFN-g + cells ( Figure 1C ). This decrease in IFN-g protein production was not due to decreased transcription of Ifng mRNA ( Figure S1B ). A central regulator of T cell mRNA translation and effector function is the mammalian target of rapamycin complex 1 (mTORC1) (Powell and Delgoffe, 2010; Zeng and Chi, 2013) . Withdrawal of either glucose or glutamine suppressed mTORC1 activity in activated T cells, as measured by reduced phosphorylation of the mTORC1 targets S6K, rpS6, and 4E-BP1 (Figure 1D) . Total S6K protein was also reduced in T cells starved of glucose or glutamine ( Figure 1D ).
We next assessed whether the effect of glucose availability on T cell cytokine production was reversible. CD8 + Teff cells were starved of glucose for 5 hr, followed by re-introduction of 25 mM glucose for 1 hr, and IFN-g production by Teff cells was measured by flow cytometry. While glucose withdrawal promoted a 5-fold reduction in the frequency of IFN-g + CD8 + T cells, re-introduction of glucose for 1 hr restored the ability of glucosestarved Teff cells to produce IFN-g ( Figure 1E ). Teff cell viability was maintained during this culture period despite acute removal of glucose ( Figure 1F ).
Finally, we examined the effect of glucose availability on T cell metabolism. Cellular ATP concentrations were maintained in T cells after acute glucose starvation ( Figure 1G ). To explore this further, we cultured Teff cells for 5 hr under various glucose concentrations, and assessed their bioenergetic profiles via Seahorse assay (Wu et al., 2007) . The extracellular acidification rate (ECAR), a measure of extracellular pH that positively co-relates with glycolysis in lymphocytes , decreased in CD8 + T cells as glucose concentration decreased, despite the presence of IL-2 to drive glycolysis ( Figure 1H ). In parallel, we examined the mitochondrial O 2 consumption rate (OCR), a measure of OXPHOS. We found that mitochondrial OCR was maximal in CD8 + T cells at lower glucose concentrations (1.5-6 mM), and largely maintained under glucose-free conditions ( Figure 1H ). This translated as a progressive increase in the OCR:ECAR ratio as glucose concentrations decreased ( Figure S1C ). Both CD8 + and CD4 + T cells demonstrated a sharp decline in ECAR while increasing their OCR:ECAR ratio under glucose-free conditions (Figures 1H and 1I and S1D and S1E) , consistent with previous results Sukumar et al., 2013) . Mitochondrial spare respiratory capacity (SRC) is defined as the increase in OCR following uncoupling with FCCP (van der Windt et al., 2012) . SRC is the maximum oxidative potential of the mitochondria available for energy production, and is linked with increased bioenergetic advantage in T cells during recall responses and metabolic stress (van der Windt et al., 2012; van der Windt et al., 2013) . Glucose starvation promoted an increase in SRC in Teff cells (Figures 1J and S1E) . Together these data indicate that T cells display flexibility in their metabolic reprogramming in response to changing glucose availability.
Glutamine Supports T Cell Metabolism under Conditions of Glucose Limitation
Given that ATP concentrations are maintained in glucosestarved Teff cells despite reduced glycolysis, we hypothesized that Teff cells engage alternate metabolic pathways to maintain cellular bioenergetics. The non-essential amino acid glutamine is critical for activation-induced T cell proliferation (Carr et al., 2010; Wang et al., 2011) and is used in many cell types to fuel oxidative metabolism under stress conditions (Le et al., 2012; Yang et al., 2009) . Glutamine withdrawal reduced the OCR of Teff cells despite the continued presence of glucose (Figure S2A) , resulting in a decreased OCR:ECAR ratio (Figure 2A ). Glutamine withdrawal had only a minor effect on the ECAR of Teff cells ( Figure S2A ). However, unlike glucose, glutamine was required to maintain ATP concentrations in Teff cells ( Figure 2B ). The expression of genes involved in glutamine metabolism, including the glutamine transporters Snat1 and Snat2 and glutaminase (Gls), increased significantly in Teff cells under glucose withdrawal ( Figure 2C ), while glycolytic gene expression was largely unaffected ( Figure S2B ).
We next conducted stable isotope tracer analysis (SITA) with [U-
13 C]-glutamine to assess whether glutamine metabolism in T cells was altered by glucose availability (schematic in Figure S2C ). Teff cells were acutely starved of glucose, followed by culture for an additional hour with [U-
13
C]-glutamine (in glucose-free medium), and 13 C incorporation in metabolite pools was quantified by GC-MS. This approach allowed us to measure the incorporation of 13 C label into lactate and TCA cycle metabolites as they are approaching steady-state labeling ( Figure S2D ). Total concentrations of [U-
C]-glutamine-derived glutamate were elevated in glucose-starved Teff cells ( Figure 2D ), while similar concentrations of 13 C enrichment were observed in succinate, fumarate, and malate between control and glucosestarved Teff cells ( Figure 2E ), indicating that glutamine-derived TCA cycle metabolites were maintained in glucose-starved Teff cells. In contrast, Teff cells starved of glutamine displayed a depletion of TCA cycle intermediates that could not be compensated by glucose ( Figure S2E ). Citrate concentrations decreased under glucose deprivation ( Figure 2E ), which might reflect the reduced contribution of glucose to the citrate pool. The distribution of mass isotopomers in [U-
C]-glutamine-derived TCA cycle metabolites was not dramatically affected by glucose availability ( Figure S2F ).
Glucose-derived pyruvate is an important source of acetylCoA, which is a key carbon input into the TCA cycle (Owen et al., 2002) . Conventional formation of malate from [U-
13 C]-glutamine in the TCA cycle will generate malate m+4. However, decarboxylation of glutamine-derived malate (or OAA) will generate pyruvate m+3 due to the loss of one carbon as CO 2 ( Figure S2C ). If the latter pathway is active, condensation of [U-
13 C]-glutamine-derived acetyl-CoA m+2 (from PDH-mediated decarboxylation of pyruvate m+3) with [U-13 C]-glutaminederived OAA (m+4) is predicted to generate citrate m+6 (Figure S2C) . Interestingly, we found that the proportion of pyruvate m+3 increased specifically in glucose-starved Teff cells (Figures 2F and S2F) . Similarly, citrate m+6 was generated only in Teff cells deprived of glucose (Figures 2G and S2F) . Finally, activated Teff cells that are normally resistant to acute glucose withdrawal ( Figure 1F ) displayed increased levels of cell death when both glucose and glutamine were absent from the culture medium ( Figure 2H ). Collectively, these data highlight a central role for glutamine in maintaining T cell metabolism and viability. previous results , Thr-172 phosphorylation of the AMPKa subunit in T cells was increased by either glucose or glutamine deprivation ( Figure 3A ). S6K phosphorylation was elevated in AMPKa1-deficient (Prkaa1 À/À ) Teff cells relative to control Teff cells and remained elevated when cells were cultured in medium lacking glucose or glutamine ( Figure 3A ). Although control and AMPKa1-deficient T cells displayed similar proliferation rates under full glucose (25 mM) conditions, Prkaa1 À/À T cells displayed reduced proliferation when stimulated under low glucose concentrations (3-6 mM) ( Figure 3B ).
AMPK Regulates T Cell Effector Function in Response to
T cell viability between genotypes was not affected during these short culture periods ( Figure S3A ). We next assessed the effect of glucose availability on cytokine production by Prkaa1 (I) Prkaa1 +/+ (white) or Prkaa1 À/À (black) Teff cells were cultured in 5 mM glucose and total RNA isolated from fractions were analyzed for Ifng expression by qPCR.
Data are presented as in (G) for biological triplicate samples.
T cells displayed greater resistance to suppression of IFN-g production by glucose limitation ( Figure 3C Figures S3B and S3C ). Given that Ifng mRNA levels in Teff cells were not significantly affected by glucose availability (Figure S1B ), one possibility for the reduced staining intensity of IFN-g in glucose-starved T cells was the differential translation of Ifng mRNA, which we assessed by polysome fractionation ( Figure 3E ). Polysome profiles of Teff cells cultured under glucose-free versus full glucose conditions revealed a reduction in the polysome fraction and decrease in the polysome-to-monosome (P:M) ratio in glucose-starved Teff cells ( Figure 3F ), indicative of reduced mRNA translation (Jaramillo et al., 2011) . The majority of Ifng mRNA in Teff cells cultured under high-glucose conditions was associated with heavy polysome fractions (fractions 14 and above), indicating active translation of this transcript ( Figure 3G Figure 3I ). mRNA transcripts for Gapdh were similarly enriched in polysomes from glucose-starved Prkaa1 À/À Teff cells ( Figure S3E ).
AMPK Regulates Metabolic Adaptation in Activated T Cells
We next examined the influence of AMPK on Teff cell metabolism. Under standard growth conditions, Prkaa1 À/À Teff cells displayed a modest increase in OCR relative to control T cells, but no difference in ECAR ( Figure S4A ). Glucose starvation induced a large drop in ECAR for both control and Prkaa1
T cells ( Figure S4B ). However, both the OCR ( Figure 4A ) and SRC ( Figure 4B ) of Prkaa1 À/À T cells were significantly reduced by glucose withdrawal compared to control Teff cells. Analysis of adenylate concentrations by LC-MS revealed a decreased ATP:AMP ratio in AMPKa1-deficient T cells, which decreased further under glucose withdrawal ( Figure 4C ). Notably, ATP concentrations were largely maintained in control T cells upon glucose withdrawal, but decreased by $50% in Prkaa1 À/À Teff cells, whereas AMP concentrations were elevated in Prkaa1
T cells regardless of glucose concentration ( Figure S4C ). Given the dependence of OXPHOS, mitochondrial respiratory capacity, and ATP maintenance on AMPKa1 expression in Teff cells, we next assessed the impact of AMPKa1 loss on Teff cell metabolic reprogramming. Prkaa1 À/À Teff cells failed to upregulate the expression of genes involved in glutamine metabolism upon glucose withdrawal and maintained expression of glucose metabolism genes including Glut1 and Ldha ( Figure 4D ). The conversion of glutamine to glutamate, which is enhanced in Teff cells by glucose withdrawal (Figure 2D ), was lower in glucose-starved Prkaa1 À/À Teff cells ( Figures 4E and S4D) .
Moreover, the total amount of glutamine-derived TCA cycle intermediates (including citrate, succinate, fumarate, and malate) was lower in Prkaa1 À/À Teff cells upon glucose starvation (Figures 4F and S4D ). The distribution of mass isotopomers in [U-
13
C]-glutamine-derived metabolites was similar between control and Prkaa1 À/À Teff cells ( Figure S4E ). However,
C]-glutamine-derived pyruvate m+3 ( Figure 4G ) and citrate m+6 (Figure 4H) Figures 5C and 5D) . However, the total number of CD4 + T lymphocytes recovered from the mLN and cLP of recipient mice was lower in animals that received Prkaa1 À/À CD4 + T cells ( Figure S5C ). This translated into a 5-fold reduction in the total number of inflammatory Th1 or Th17 cells in the mLN and cLP of mice that received naive Prkaa1 À/À CD4 + T cells ( Figure 5E ). Histologic analysis of colon specimens revealed moderate-to-severe colitis in mice receiving wild-type donor CD4 + T cells, marked by globet cell loss and severe mononuclear infiltration into the mucosa and extension into the muscularis and serosa ( Figure 5F ). In contrast, the colons of mice that received Prkaa1 À/À CD4 + T cells showed almost no colitis with intact epithelial structures and reduced inflammatory infiltrate ( Figures 5F and 5G) . (dpi), the total number of leukocytes was reduced in the bronchoalveolar lavage (BAL), lungs and mediastinal lymph node (LN) of IAV-infected KO-T mice compared to littermate controls ( Figure S6B ). The frequency and total number of T cells was lower in the BAL and lungs of KO-T mice ( Figure S6C ), which was associated with decreased frequency and total numbers of CD4 + and CD8 + T cells ( Figures 6A and S6D ). In addition, the frequency and total number of CD8 + T cells specific for the immunodominant IAV nucleoprotein (NP) epitope was reduced in the BAL ( Figure 6B ) and lungs ( Figure S6E ) of IAV-infected KO-T mice. In IAV-infected WT-T and KO-T mice, the frequency of pulmonary T cells producing IFN-g was similar following stimulation with whole UV-inactivated IAV, hemagglutinin (HA) peptide (specific for CD4 + T cells), or NP peptide (specific for CD8 + T cells) at day 9 or 12 post-infection ( Figures 6C and 6D , left panels). However, consistent with the reduced T cell numbers in infected KO-T mice, there was a reduction in the total number of IFN-g-producing CD4 + and CD8 + T cells in the BAL of IAV-infected KO-T mice relative to control animals ( Figures 6C  and 6D , right panels). Considering the quantity and quality of innate immunity (including macrophages) is intact in KO-T mice, we observed no difference in pulmonary viral load during early phases of infection ( Figure 6E ). We next investigated the role of AMPK in T cell-mediated immune responses to the Gram-positive bacterium L. monocytogenes (Lm) by infecting control and KO-T mice with a variant of Lm expressing OVA (rLmOVA) (Figure S7A ). KO-T mice displayed a reduced number of OVA-specific CD8 + T cells 7 days post infection with rLmOVA compared to control littermates ( Figures 7A and 7B ). Similar to infection with IAV, KO-T mice displayed a reduction in total CD4 + and CD8 + T cell numbers following rLmOVA infection relative to controls ( Figure S7B ). The reduction in OVA-specific T cells was not due to delayed kinetics of expansion, as mice with conditional deletion of AMPKa1 displayed a lower percentage of OVA-specific T cells over the course of infection (Figure 7C) . Re-stimulation of splenocytes from day 7 infected mice in vitro revealed a reduction in the number of IFN-g + CD8 + ( Figures 7D-E) and IFN-g + CD4 + ( Figure S7C ) T cells in KO-T mice. At 3 dpi, bacterial load was elevated in the liver of infected KO-T mice compared to control animals and a similar trend was also observed in the spleens of infected mice ( Figure S7D (E) Viral load in the lungs of infected WT-T and KO-T mice 3 and 6 dpi. All data are expressed as the mean ± SEM for 4-5 mice/group. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. (legend continued on next page) pathogenic challenge. WT-T and KO-T mice were infected with rLmOVA (as in Figure S7A ), and activated CD8 + Teff cells (CD44   hi   CD62L lo ) were isolated 7 dpi and subjected to bioenergetic profiling ex vivo (Figures 7G-7I ). CD8 + Teff cells isolated from LmOVA-infected KO-T mice displayed reduced basal mitochondrial OCR relative to control T cells ( Figure 7G) . Moreover, the maximal mitochondrial oxidative capacity ( Figure 7H ) and SRC ( Figure 7I ) of AMPKa1-deficient Lm-specific CD8 + Teff cells were reduced relative to control Teff cells.
KO-T WT-T KO-T WT-T KO-T WT-T KO-T WT-T KO-T WT-T KO-T WT-T KO-T WT-T KO-T
To assess the impact of AMPKa1 on T cell metabolic reprogramming in vivo, we examined metabolic gene expression in Teff cells isolated from rLmOVA-infected mice. Teff cells from KO-T mice displayed reduced expression of glucose (Glut1, Ldha) and glutamine (Snat1, Snat2, Gls, Got1, Gpt1) metabolism genes ( Figure 7J ). We next measured glucose uptake by Teff cells in vivo using the fluorescent glucose analog 2-NBDG (O'Sullivan et al., 2014). While larger than conventional glucose due to its fluorescent tag, 2-NBDG is actively transported into cells similar to D-glucose and can be used to image glucose uptake in live cells (O'Neil et al., 2005) . WT-T and KO-T mice were infected with rLmOVA, injected with 2-NBDG 7 dpi and 2-NBDG uptake by CD8 + K b / SIINFEKL + T cells in vivo was assessed by flow cytometry. 2-NBDG uptake by antigen-specific CD8 + T cells from KO-T mice was $30% lower relative to WT-T cells ( Figure 7K ). Finally, we measured ATP concentrations in CD8 + T cells sorted from rLmOVA-infected mice (7 dpi). No difference in ATP concentrations was observed for naive T cells (CD44 lo CD62L hi ) of each genotype ( Figure 7L ). However, ATP concentrations were higher in Teff cells (CD44 hi CD62L lo ) from WT-T mice, while ATP concentrations in KO-T CD8 + Teff cells were similar to naive T cells ( Figure 7L ). Together, these data indicate that AMPKa1 is required to maintain the metabolic homeostasis of Teff cells in vivo.
DISCUSSION
Much of our understanding of T cell metabolism is based on the metabolic programs engaged by Teff cells in vitro. Under these conditions, where nutrient availability is in excess relative to normal physiological concentrations, glycolytic metabolism (i.e., the Warburg effect) is a dominant metabolic program in Teff cells. However, our results indicated that Teff cells are capable of adapting their metabolism in response to reduced glucose availability, even in the presence of TCR-mediated metabolic reprogramming that favors glycolytic metabolism. We found that Teff cells actively engage glutamine-dependent OXPHOS to maintain ATP concentrations and cell viability under low glucose conditions. The energy sensor AMPK played a key role in this metabolic adaptation. AMPKa1-deficient T cells displayed reduced metabolic plasticity in response to glucose limitation in vitro, and reduced metabolic activity and lower ATP levels during pathogenic challenge in vivo. The reversible metabolic checkpoint induced in lymphocytes is reminiscent of AMPK function in tumor cells, where AMPK triggers a cell cycle checkpoint to maintain cell viability under poor nutrient conditions (Jones et al., 2005) . We speculate that T cells display metabolic flexibility to help preserve cell viability and effector function in the face of varying environmental conditions. Energetic homeostasis can be achieved by increasing ATP production or reducing energy expenditure. Our data suggested that Teff cells engage both strategies to adapt to glucose limitation. We found that T cells actively dampened energyconsuming processes including cell proliferation and cytokine production when nutrients were low. IFN-g production was highly sensitive to glucose availability. Shifting Teff cells to physiological glucose concentrations ($5 mM) promoted a significant decrease in Ifng mRNA translation and overall IFN-g production. AMPK acts as a key regulator of this process by suppressing cytokine mRNA translation under conditions of reduced glucose availability. Stimulation of AMPK activity by AICAR or phenformin actively suppressed IFN-g production by Teff cells, while AMPKa1-deficient Teff cells appeared locked in a pro-growth state marked by increased IFN-g production, even when metabolic conditions were unfavorable.
Conversely, we found that T cells actively engaged alternate pathways of ATP production to maintain T cell energetic homeostasis under conditions of metabolic stress. Glutamine-dependent OXPHOS was essential for maintaining T cell energetic homeostasis, as removal of glutamine promoted the rapid depletion of both TCA cycle intermediates and cellular ATP in Teff cells, even when glucose was readily available. These data argue against the Warburg effect as the main metabolic program for ATP production in activated T cells. Glucose starvation triggered an AMPKa1-dependent shift in Teff cell metabolic reprogramming by increasing the expression of genes involved in glutamine uptake and glutaminolysis (i.e., Snat1, Snat2, Gls) . In addition, our SITA experiments indicate that T cells with low glycolytic flux can engage a novel metabolic shunt involving the conversion of glutamine to pyruvate. Engaging this metabolic shunt allows glucose-starved T cells to maintain a pool of pyruvate, derived from glutamine rather than glucose, which can be converted to acetyl-CoA and maintain TCA cycle homeostasis, similar to adaptive strategies used by glucose-starved tumor cells (Le et al., 2012; Yang et al., 2009 ). AMPK activity is required for these processes, as AMPKa1-deficient T cells are less able to engage glutamine oxidation to compensate for loss of glycolysis-derived ATP.
To date, the role of AMPK in T cell function has been controversial. T cells isolated from whole body AMPKa1-deficient mice display normal responses to mitogenic stimulation in vitro (MacIver et al., 2011; Mayer et al., 2008) , while impaired central memory T cell (Tcm) generation has been reported using an independent T cell-specific AMPKa1-deleted mouse strain . These data are in sharp contrast with the murine model of whole-body AMPKa1 deletion, which leads to the accumulation of activated CD8 + T cells (MacIver et al., 2011 ) and exacerbated T cell-mediated pathology in an in vivo model of autoimmunity (Nath et al., 2009 Our data point to AMPK-dependent control of T cell metabolism as a key determinant of T cell effector responses. While AMPKa1-deficient T cells displayed a lower ATP:AMP ratio relative to control T cells, AMPKa1 was not required for TCR-mediated proliferation or metabolic programming when glucose was in excess. Rather, AMPK was required to modulate T cell metabolism and effector function when glucose was scarce. Under low glucose conditions, Prkaa1 À/À T cells displayed reduced levels of glutamine-dependent OXPHOS and were unable to maintain cellular ATP levels, leading to increased bioenergetic deficit and cell death. Similarly, AMPKa1-deficient Teff cells displayed reduced metabolic gene expression, lower glucose uptake, and reduced OXPHOS and mitochondrial SRC in response to pathogenic challenge in vivo. SRC represents increased mitochondrial electrochemical potential, which can be used to generate ATP, and is a key index of T cell metabolic fitness (Pearce and Pearce, 2013; van der Windt et al., 2012) . Impaired nutrient utilization and reduced SRC may explain the failure of AMPKa1-deficient Teff cells to maintain cellular ATP concentrations, survive metabolic challenges in vitro, and mount robust effector responses in vivo. Overall, our study provides evidence that T cells have evolved a rapid nutrient-sensing system that influences the metabolic fitness of responding Teff cells in vivo. This metabolic checkpoint-regulated by the energy sensor AMPK-ultimately influences the size (cell number) and strength (cytokine production) of the T cell response. We hypothesize that this intrinsic system evolved to maintain mitochondrial function and cellular energy levels in T cells to support the viability and phenotypic stability of Teff cells in microenvironments where O 2 and nutrients might be limiting. This raises the possibility that other metabolic sensors, such as HIF-1a (Wang and Green, 2012a) or mTOR (Powell and Delgoffe, 2010; Zeng and Chi, 2013) , might regulate T cell effector function through similar effects on T cell bioenergetics. In this regard, AMPK agonists, such as metformin or A-769662 (Vincent et al., 2014) , might provide new ways to shape T cellmediated immune responses by altering T cell metabolism and mitochondrial function. , OT-I, and C57BL/6-Ly5.1 mice were bred and maintained under specific pathogen-free conditions at McGill University under approved protocols.
T Cell Purification and Culture
CD4
+ and CD8 + T cells were purified from spleen and peripheral lymph nodes by negative selection and cultured in T cell medium (TCM) containing IMDM supplemented with 10% FBS, L-glutamine, penicillin-streptomycin, and 2-ME as previously described (Jones et al., 2007; MacIver et al., 2011) . For nutrient limitation conditions and SITA experiments, cells were cultured in TCM containing 10% dialyzed FBS.
Flow Cytometry
Single-cell suspensions were stained with fluorescently conjugated Abs as previously described (Jones et al., 2007; MacIver et al., 2011) . Antigen-specific CD8 + T cells were quantified using H2-K -NP tetramers. Cell viability was assessed using the Fixable Viability Dye eFluorÒ 780 (eBioscience). ICS was performed using specific fluorochrome-labeled mAbs (eBioscience) and flow cytometry as previously described (MacIver et al., 2011) . For 2-NBDG uptake in vivo, mice were injected intravenously (i.v.) with 100 mg 2-NBDG/mouse 15 min prior to analysis (O'Sullivan et al., 2014) . Flow cytometry was performed on a Gallios or LSR II flow cytometer and analyzed with FlowJo software.
Metabolic Assays OCR, ECAR, and SRC were determined using a Seahorse XF96 Extracellular Flux Analyzer following established protocols . ATP levels were determined using CellTiter-GloÒ Luminescent Cell Viability reagent (Promega). GC-MS-and LC-MS-based metabolomics studies were performed using previously described methods Faubert et al., 2013) . For SITA experiments, T cells were cultured with [U-
13 C]-glucose or [U-
13
C]-glutamine (Cambridge Isotope Laboratories) for 0.5-6 hr. Mass isotopomer distribution was determined using a custom algorithm developed at McGill University (McGuirk et al., 2013) .
Immunoblotting and Quantitative Real-Time PCR Immunoblotting and qPCR were conducted as previously described (MacIver et al., 2011) . Protein lysates were generated using AMPK Lysis Buffer supplemented with protease and phosphatase inhibitors . Primary and secondary Abs and qPCR primer sets are listed in Supplemental Experimental Procedures.
Adoptive Transfers and Infection Models
For development of T cell-mediated colitis, CD4 + CD25
À T cells were transferred into Tcrb À/À or Rag2 À/À recipient mice, and inflammatory infiltration into the cLP assessed 21 days later by flow cytometry and histological examination of H&E stained colon sections. Cytokine production in the mLN and cLP was determined by ICS. Histopathological scoring is described in Supplemental Experimental Procedures. Influenza A virus (IAV) infections were performed with mouse-adapted IAV H1N1 strain A/Puerto Rico/8/34 (PR8) as previously described . Mice were injected intravenously with a sublethal dose of rLmOVA (5 3 10 4 cfu/ml) as described (Jones et al., 2007 
